Priority Date: 31.01.12 (US 201261592923P)

SITAXSENTAN DERIVATIVE

  • Application ID: EP13743422
  • Status: The patent has been granted

Applicant

Technology company logo small
Technology Company

Attorney

Employment test 51 - 200 employees
Company dna hoffmann eitle
operating since 1892
Headquarter in Munich and 6 offices
active in Legal Services and IP Portfolio Processing

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 222 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 31.01.2012 - Priority Date (US 201261592923P)
  • 08.08.2013 - Publication A1 (WO2013115162)
  • 10.12.2014 - Publication A1 (EP2810943)
  • 27.09.2017 - Publication B1 (EP2810943)